356 related articles for article (PubMed ID: 30011940)
21. TDP2-dependent non-homologous end-joining protects against topoisomerase II-induced DNA breaks and genome instability in cells and in vivo.
Gómez-Herreros F; Romero-Granados R; Zeng Z; Alvarez-Quilón A; Quintero C; Ju L; Umans L; Vermeire L; Huylebroeck D; Caldecott KW; Cortés-Ledesma F
PLoS Genet; 2013; 9(3):e1003226. PubMed ID: 23505375
[TBL] [Abstract][Full Text] [Related]
22. TDP2/TTRAP is the major 5'-tyrosyl DNA phosphodiesterase activity in vertebrate cells and is critical for cellular resistance to topoisomerase II-induced DNA damage.
Zeng Z; Cortés-Ledesma F; El Khamisy SF; Caldecott KW
J Biol Chem; 2011 Jan; 286(1):403-9. PubMed ID: 21030584
[TBL] [Abstract][Full Text] [Related]
23. SUMO-Targeted DNA Translocase Rrp2 Protects the Genome from Top2-Induced DNA Damage.
Wei Y; Diao LX; Lu S; Wang HT; Suo F; Dong MQ; Du LL
Mol Cell; 2017 Jun; 66(5):581-596.e6. PubMed ID: 28552615
[TBL] [Abstract][Full Text] [Related]
24. Novel TDP2-ubiquitin interactions and their importance for the repair of topoisomerase II-mediated DNA damage.
Rao T; Gao R; Takada S; Al Abo M; Chen X; Walters KJ; Pommier Y; Aihara H
Nucleic Acids Res; 2016 Dec; 44(21):10201-10215. PubMed ID: 27543075
[TBL] [Abstract][Full Text] [Related]
25. Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II.
Lee KC; Bramley RL; Cowell IG; Jackson GH; Austin CA
Biochem Pharmacol; 2016 Mar; 103():29-39. PubMed ID: 26794000
[TBL] [Abstract][Full Text] [Related]
26. Physiological concentrations of glucocorticoids induce pathological DNA double-strand breaks.
Akter S; Shimba A; Ikuta K; Mahmud MRA; Yamada S; Sasanuma H; Tsuda M; Sone M; Ago Y; Murai K; Tanaka H; Takeda S
Genes Cells; 2023 Jan; 28(1):53-67. PubMed ID: 36415926
[TBL] [Abstract][Full Text] [Related]
27. RAD54L2 counters TOP2-DNA adducts to promote genome stability.
D'Alessandro G; Morales-Juarez DA; Richards SL; Nitiss KC; Serrano-Benitez A; Wang J; Thomas JC; Gupta V; Voigt A; Belotserkovskaya R; Goh CG; Bowden AR; Galanty Y; Beli P; Nitiss JL; Zagnoli-Vieira G; Jackson SP
Sci Adv; 2023 Dec; 9(49):eadl2108. PubMed ID: 38055822
[TBL] [Abstract][Full Text] [Related]
28. Untangling trapped topoisomerases with tyrosyl-DNA phosphodiesterases.
Zagnoli-Vieira G; Caldecott KW
DNA Repair (Amst); 2020 Oct; 94():102900. PubMed ID: 32653827
[TBL] [Abstract][Full Text] [Related]
29. Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity.
Sciascia N; Wu W; Zong D; Sun Y; Wong N; John S; Wangsa D; Ried T; Bunting SF; Pommier Y; Nussenzweig A
Elife; 2020 Feb; 9():. PubMed ID: 32057297
[TBL] [Abstract][Full Text] [Related]
30. TDP2, TOP2, and SUMO: what is ZATT about?
Zagnoli-Vieira G; Caldecott KW
Cell Res; 2017 Dec; 27(12):1405-1406. PubMed ID: 29160298
[TBL] [Abstract][Full Text] [Related]
31. A human 5'-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage.
Cortes Ledesma F; El Khamisy SF; Zuma MC; Osborn K; Caldecott KW
Nature; 2009 Oct; 461(7264):674-8. PubMed ID: 19794497
[TBL] [Abstract][Full Text] [Related]
32. TDP2 promotes repair of topoisomerase I-mediated DNA damage in the absence of TDP1.
Zeng Z; Sharma A; Ju L; Murai J; Umans L; Vermeire L; Pommier Y; Takeda S; Huylebroeck D; Caldecott KW; El-Khamisy SF
Nucleic Acids Res; 2012 Sep; 40(17):8371-80. PubMed ID: 22740648
[TBL] [Abstract][Full Text] [Related]
33. MRN, CtIP, and BRCA1 mediate repair of topoisomerase II-DNA adducts.
Aparicio T; Baer R; Gottesman M; Gautier J
J Cell Biol; 2016 Feb; 212(4):399-408. PubMed ID: 26880199
[TBL] [Abstract][Full Text] [Related]
34. Ubiquitin stimulated reversal of topoisomerase 2 DNA-protein crosslinks by TDP2.
Schellenberg MJ; Appel CD; Riccio AA; Butler LR; Krahn JM; Liebermann JA; Cortés-Ledesma F; Williams RS
Nucleic Acids Res; 2020 Jun; 48(11):6310-6325. PubMed ID: 32356875
[TBL] [Abstract][Full Text] [Related]
35. Differential and common DNA repair pathways for topoisomerase I- and II-targeted drugs in a genetic DT40 repair cell screen panel.
Maede Y; Shimizu H; Fukushima T; Kogame T; Nakamura T; Miki T; Takeda S; Pommier Y; Murai J
Mol Cancer Ther; 2014 Jan; 13(1):214-20. PubMed ID: 24130054
[TBL] [Abstract][Full Text] [Related]
36. Biochemical characterization of human tyrosyl-DNA phosphodiesterase 2 (TDP2/TTRAP): a Mg(2+)/Mn(2+)-dependent phosphodiesterase specific for the repair of topoisomerase cleavage complexes.
Gao R; Huang SY; Marchand C; Pommier Y
J Biol Chem; 2012 Aug; 287(36):30842-52. PubMed ID: 22822062
[TBL] [Abstract][Full Text] [Related]
37. Deazaflavin Inhibitors of TDP2 with Cellular Activity Can Affect Etoposide Influx and/or Efflux.
Komulainen E; Pennicott L; Le Grand D; Caldecott KW
ACS Chem Biol; 2019 Jun; 14(6):1110-1114. PubMed ID: 31091068
[TBL] [Abstract][Full Text] [Related]
38. Inactivating TDP2 missense mutation in siblings with congenital abnormalities reminiscent of fanconi anemia.
Zagnoli-Vieira G; Brazina J; Van Den Bogaert K; Huybrechts W; Molenaers G; Caldecott KW; Van Esch H
Hum Genet; 2023 Sep; 142(9):1417-1427. PubMed ID: 37558815
[TBL] [Abstract][Full Text] [Related]
39. The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes.
Xiao H; Goodrich DW
Oncogene; 2005 Dec; 24(55):8105-13. PubMed ID: 16091739
[TBL] [Abstract][Full Text] [Related]
40. DNA double-strand breaks with 5' adducts are efficiently channeled to the DNA2-mediated resection pathway.
Tammaro M; Liao S; Beeharry N; Yan H
Nucleic Acids Res; 2016 Jan; 44(1):221-31. PubMed ID: 26420828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
